Data / Form D filings / North Texas Renal Management XII, LLC
North Texas Renal Management XII, LLC: Form D filing
North Texas Renal Management XII, LLC, a health care company in Dallas, United States, filed a Form D with the SEC in 2024. The latest, on April 25, 2024, reports $627,632 sold of a $1.6 million offering to 42 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1505 LBJ FREEWAY, SUITE 700, Dallas, United States, 75234
- Phone
- (214) 358-2300
- Industry
- Other Health Care
- Entity type
- Limited Liability Company
- Incorporated in
- Texas
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2020966
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 25, 2024 | New notice | $1,634,210 | $627,632 | $1,006,578 | 42 | Apr 17, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jyothsna M. Kodali, M.D. | Executive Officer, Director | |
| Ali M. Khalil, M.D. | Director | |
| Daniel M. Richey, D.O. | Director | |
| Steven M. Gieser, M.D. | Executive Officer, Director | |
| Geoffrey Walker, M.D. | Executive Officer, Director |
Every Form D from the week of Apr 22, 2024 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what North Texas Renal Management XII, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.